Well, that didn't take long - Australia's ECS Botanics (ASX:ECS) has found a buyer for its hemp food and wellness division.In June ECS Botanics released its strategy for a major shift that will see it focusing its operations entirely on medicinal cannabis, which makes up the vast majority of...
Australia's Incannex (ASX: IHL) has been given the go-ahead for a clinical trial involving a formulation containing cannabidiol (CBD) and hydroxychloroquine (HCQ).The Bellberry Human Research Ethics Committee has granted approval for a phase 1 clinical trial investigating IHL-675A, a multi-use, anti-inflammatory drug."There’s a growing trend whereby patients are using...
After running its own hemp program since 2009, the US state of Vermont is ending it and handing over control to the USDA.Early this month, the Vermont Agency of Agriculture, Food & Markets (VAAFM) wrote to the Chief of the USDA's U.S. Domestic Hemp Production Program indicating an intention...
Texas Agriculture Commissioner Sid Miller is pushing for more effective cannabis policy in the Lone Star State.Commissioner Miller has been a solid supporter of hemp for years and has stated his case for expansion of medical cannabis use in the state in an editorial published last week.There is some...
Australian health and wellness product distributor Wellnex Life Limited (ASX: WNX) has entered into a joint venture with local medical cannabis firm OneLife Botanicals.The 50/50 JV has been formed for the purpose of bringing registered medicinal cannabis and hemp-based products to Australian and international markets.It's envisioned the arrangement will...
The first company in Australia licensed to cultivate medicinal cannabis is now under the control of administrators.Medifarm was the first Australian medical cannabis company to be awarded government licences to cultivate and manufacture medical cannabis in this country. The company originally started operating in partnership with Israeli firm Tikun...
The first cannabis company to list on New Zealand's stock exchange has signed a significant agreement with a German pharmaceutical firm.Cannasouth Bioscience Ltd, a subsidiary of Cannasouth (NZX: CBD), announced last Thursday the inking of a deal with WEECO Pharma GMBH, one of Germany's leading medical cannabis importers.To run...
Canada-headquartered cannabinoid company MediPharm Labs Corp. intends selling MediPharm Labs Australia to OneLife Botanicals.Melbourne (Australia) based OneLife Botanicals is picking up the Australian company lock, stock and barrel aside from international contracts outside of Australia and New Zealand, which will remain with MediPharm Labs Corp.Assuming the deal passes muster,...
Australia's Little Green Pharma has racked up another medical cannabis supply agreement with a company in Germany.Perth-headquartered LGP announced the agreement with Frankfurt-headquartered pharmaceutical wholesaler Ilios Santé GmbH, which is a wholly-owned subsidiary of German medical cannabis healthcare company, The Bloomwell Group.The arrangement involves supply of an LGP white...
A "world-first" Australian/New Zealand trial of transdermal CBD gel in adults with focal epilepsy has seen the majority of patients experience a reduction in seizures.Focal epilepsy is a condition in which the main symptom is recurring seizures that affect one half of the brain. It's the most common form...
